The Colloid Crystalloid Question • Is one of the oldest. • Basic yet fundamental question. • The first intervention given. • To every patient. • Often several litres. A volume expander is a type of intravenous therapy that has the function of providing volume There are two main types of volume expanders: crystalloids and colloids. Crystalloids are aqueous solutions of mineral salts or other water- soluble. Colloids and crystalloids are types of fluids that are used for fluid replacement, often intravenously (via a tube straight into the blood).
|Published (Last):||25 March 2004|
|PDF File Size:||12.45 Mb|
|ePub File Size:||10.90 Mb|
|Price:||Free* [*Free Regsitration Required]|
Using starches, dextrans, albumin or FFP colloici evidenceor gelatins low-certainty evidenceversus crystalloids probably makes little or no difference to mortality. Starches probably slightly increase the need for blood transfusion and RRT moderate-certainty evidenceand albumin or FFP may make little or no difference to the need for renal replacement therapy low-certainty evidence.
Colloids contain larger insoluble colkoidi, such as gelatin ; blood itself is a colloid. Intravenous sugar solutionssuch as with glucose also called dextrosehave the advantage of providing some energy, and may thereby provide the entire or part of the energy component of parenteral nutrition.
A patient at rest uses only 25 percent of the oxygen available in their blood.
Volume expander – Wikipedia
The evidence is current to February Critically ill people may lose fluid because of serious conditions, infections e. Participants had traumaburns, or medical conditions such as sepsis.
There is also a risk of hemodilution, which may occur with crystalloid administration.
Crystalloids exert colloidk significant hydrostatic effect on capillaries that may lead to extracellular fluid accumulation. In these situations, the only alternatives are blood transfusions, packed red blood cells, or oxygen therapeutics if available.
For some outcomes, we had very few studies, which reduced our confidence in the evidence. The body detects the lower hemoglobin level, and compensatory mechanisms start up. We compared a colloid suspended in any crystalloid solution versus a crystalloid isotonic or hypertonic. Crystalloids are low-cost salt solutions e.
Crystalloids and colloids are the primary options for colloldi fluid resuscitation. We are uncertain whether using dextrans, albumin or FFP, or crystalloids affects the need for blood transfusion.
We found little or no difference in allergic reactions for the use of dextrans four studiesgelatins one studyand albumin or FFP one study.
It is an intravenous colooidi that behaves much like blood filled with albumins. We found low-certainty evidence that there may be little or no difference between gelatins or crystalloids in mortality: Blood substitutes Intravenous fluids.
Data collection and analysis: Some study authors did not report study methods clearly and many did not register their studies before they started, so we could not be certain whether the study outcomes were decided before or after they saw the results. Colloids or crystalloids for fluid replacement in critically people Background Critically ill people may lose large amounts of blood because of trauma or burnsor have serious conditions or infections e.
Goal-directed fluid therapy is possible with either crystalloid or HES. In summary, crystalloids seem to be the best choice for d evaporative losses, providing maintenance fluids, and expanding cokloidi extracellular volume.
Crystalloid vs colloid rx
The choice of fluids may also depend on the chemical properties of the medications being given. Starches versus crystalloids We found moderate-certainty evidence that there is probably little or no difference between using starches or crystalloids in mortality at: We found moderate-certainty evidence that using starches for fluid replacement probably slightly increases the need for renal replacement therapy.
There are many clinical factors that may affect the decision to use a crystalloid versus colloid fluid. Key results We found moderate-certainty evidence that using colloids starches; dextrans; or albumin or FFP compared to crystalloids for fluid replacement probably makes little or no difference to the number of critically ill people who die within 30 or 90 days, or by the end of study follow-up. There are two main types of volume expanders: Certainty of the evidence Some study authors did not report study methods clearly and many did not register their studies before they started, so we could not be certain whether the study outcomes were decided before or after they saw the results.
The primary outcome measure was the incidence of gastrointestinal GI morbidity on postoperative day 5. The Cochrane Database of Systematic Reviews. All articles with dead external links Articles with dead external links from May Wikipedia articles in need of updating from November All Wikipedia articles in need of updating.
Colloid or crystalloid solutions may be used for this purpose. We included randomised controlled criwtalloidi RCTs and quasi- RCTs of critically ill people who required fluid col,oidi replacement in hospital or emergency out-of-hospital settings. We noted risk of selection bias in some studies, and, as most studies were not prospectively registered, risk of selective outcome reporting. This page was last edited on 4 Novemberat Peripheral venous catheter Peripherally inserted central catheter Seldinger technique Central venous catheter.
Cristaloidi second greatest need is replacing the lost volume. We also found low-certainty evidence that using gelatins or crystalloids may make little or no difference to the number of deaths within each of these time points. We found little or no difference in allergic reactions RR 6. Gelatins versus crystalloids We found low-certainty evidence that there may be little or no difference between gelatins or crystalloids in mortality: We found little or no difference between starches or crystalloids in allergic reactions, but fewer participants given crystalloids reported itching or rashes.
We found moderate-certainty evidence that there is probably little or no difference between using albumin or FFP or cristaalloidi crystalloids in mortality at: Secondary outcome measures included the incidence of postoperative complications, hospital length of stay, and the effect of trial fluids on coagulation and inflammation.
Colloids can be man-made e. With enough blood loss, ultimately red blood cell levels drop too low for adequate tissue cristallkidi, even if volume expanders maintain circulatory volume.